Researchers Further Support Findings Showing Cost Savings of RSV Vaccination
Researchers found cost-effective benefits with vaccination against respiratory syncytial virus (RSV) among individuals 60 years and older, according to a study conducted by the University of Michigan and the CDC. The results furthered findings published in …